Plain-English translation of NCT06414057 on ClinicalTrials.gov ↗ ·
This study is offering a cervical cancer prevention vaccine called Gardasil-9 and a simple screening test to women who may have been left out of routine cancer prevention programs. The vaccine protects against nine types of human papillomavirus (HPV), which can cause cervical cancer. Researchers want to understand how well the vaccine and screening work for women who face barriers to healthcare, like homelessness or substance use.
Many women facing hardship—such as homelessness, substance use, or involvement in survival sex work—are less likely to get cervical cancer screening and vaccination through regular healthcare. This study aims to close that gap by bringing prevention directly to these communities and making it easier and more comfortable to participate.
You likely qualify if…
You likely don't qualify if…
You would visit one of three health clinics in Scotland over a 6–9 month period. At your visit, you would provide a self-taken vaginal swab sample for HPV testing—you can do this yourself in private, or ask a clinician to do it for you. You would then receive the cervical cancer vaccine (either 2 or 3 doses depending on your health needs). If your HPV test comes back positive, the research team will follow up with you to discuss next steps.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United Kingdom